UCM710

UCM710 is an endocannabinoid (eCB) hydrolysis inhibitor that increases the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neurons. UCM710 inhibits fatty acid amide hydrolase and α/β-hydrolase domain 6, but not monoacylglycerol lipase[1].

Product Specifications

CAS Number

[213738-77-3]

UNSPSC

12352005

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/ucm710.html

Solubility

10 mM in DMSO

Smiles

CCCCCC/C=C\CCCCCCCC(OCC1OC1)=O

Molecular Formula

C19H34O3

Molecular Weight

310.47

References & Citations

[1]Marrs WR, et al. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem. 2011 Aug 19;286 (33) :28723-28728.